120 related articles for article (PubMed ID: 18708974)
1. What is the impact of free drug samples on patients?
Downey LV
South Med J; 2008 Sep; 101(9):879-80. PubMed ID: 18708974
[No Abstract] [Full Text] [Related]
2. Drug industry is told to stop gifts to doctors.
Pear R
N Y Times Web; 2002 Oct; ():A1, A29. PubMed ID: 12474836
[No Abstract] [Full Text] [Related]
3. High-tech stealth being used to sway doctor prescriptions.
Stolberg SG; Gerth J
N Y Times Web; 2000 Nov; ():A1, A22. PubMed ID: 12159839
[No Abstract] [Full Text] [Related]
4. Rethinking prescribing in the United States.
Ellner A
BMJ; 2003 Dec; 327(7428):1397-400. PubMed ID: 14670892
[TBL] [Abstract][Full Text] [Related]
5. Doctors don't fall for the hard sell.
Randerson J
New Sci; 2003 Jun; 178(2401):10. PubMed ID: 14686412
[No Abstract] [Full Text] [Related]
6. Marketing drugs: debating the real cost. Concern about close ties between doctors and pharmaceutical firms are prompting new financial disclosure laws and education efforts.
Brand R
State Legis; 2008 Sep; 34(8):26-9. PubMed ID: 18754159
[No Abstract] [Full Text] [Related]
7. Doctors object as drug makers learn who's prescribing what.
Saul S
N Y Times Web; 2006 May; ():A1, C4. PubMed ID: 16718959
[No Abstract] [Full Text] [Related]
8. The devil in the detail(ing).
Morreim H
Am J Bioeth; 2010 Jan; 10(1):15-7. PubMed ID: 20077328
[No Abstract] [Full Text] [Related]
9. Huddle gets it right, most docs don't.
Rubin PH
Am J Bioeth; 2010 Jan; 10(1):17-9. PubMed ID: 20077329
[No Abstract] [Full Text] [Related]
10. Why academic medical centers should ban drug company gifts to individuals.
Strong C
Am J Bioeth; 2010 Jan; 10(1):13-5. PubMed ID: 20077327
[No Abstract] [Full Text] [Related]
11. The details are in the field.
Schwab AP
Am J Bioeth; 2010 Jan; 10(1):19-21. PubMed ID: 20077330
[No Abstract] [Full Text] [Related]
12. GP fundholding and the costs of prescribing.
Whynes DK; Baines DL; Tolley KH
J Public Health Med; 1995 Sep; 17(3):323-9. PubMed ID: 8527186
[No Abstract] [Full Text] [Related]
13. Prescribing costs.
Malcolm L
N Z Med J; 1998 Mar; 111(1061):83. PubMed ID: 9575063
[No Abstract] [Full Text] [Related]
14. Drug detailers, professionalism, and prudence.
Brody H
Am J Bioeth; 2010 Jan; 10(1):9-10. PubMed ID: 20077325
[No Abstract] [Full Text] [Related]
15. Sale of Canadian doctors' drug data goes to court.
Kondro W
Lancet; 2003 Sep; 362(9387):884. PubMed ID: 13679000
[No Abstract] [Full Text] [Related]
16. [Economic prescription of drugs].
Sonne J; Faber O
Ugeskr Laeger; 2004 Apr; 166(18):1695. PubMed ID: 15174414
[No Abstract] [Full Text] [Related]
17. Avoiding over-deterrence in managing physicians' relationships with industry.
Stell LK
Am J Bioeth; 2010 Jan; 10(1):27-9. PubMed ID: 20077334
[No Abstract] [Full Text] [Related]
18. Contact with pharmaceutical representatives: where does prudence lead?
Appelbaum PS
Am J Bioeth; 2010 Jan; 10(1):11-3. PubMed ID: 20077326
[No Abstract] [Full Text] [Related]
19. Prescribing data and cost comparisons in New Zealand.
Bishop N; Maling T
N Z Med J; 1997 Nov; 110(1056):445-6. PubMed ID: 9418844
[No Abstract] [Full Text] [Related]
20. The AAMC exhibits the behavior it condemns.
Stossel TP
Am J Bioeth; 2010 Jan; 10(1):26-7. PubMed ID: 20077333
[No Abstract] [Full Text] [Related]
[Next] [New Search]
